Compare Brimonidine 0.2% versus Latanoprost 0.005% (Xalatan) in preventing intraocular pressure after YAG laser posterior capsulotomy in patients visiting ophthalmology clinic in Ardabil city [PDF]
Background: The transient increase of intraocular pressure (IOP) following neodymium YAG laser capsulotomy can occur in a significant number of patients, which requires prophylactic treatment with IOP reducing drugs, and in some patients, postoperative ...
Eskandar-Sani, Solmaz+2 more
core +2 more sources
Multidrug regimens for glaucoma treatment often result in adherence issues due to inconvenience; these issues may be improved with fixed-dose combination drugs. The ophthalmic solution of ripasudil-brimonidine fixed-dose combination (RBFC; K-232) is the first treatment combining a Rho kinase inhibitor and an α2-adrenoceptor agonist, and has ...
Hidenobu Tanihara+18 more
openaire +2 more sources
INTRODUCTION[|] This study aimed to compare pupil diameters in light and dark conditions after instillation of 0.15% brimonidine drops in eyes with and without pseudoexfoliation syndrome (PES).[¤]METHODS[|]Forty eyes of 40 patients in whom 0.15 ...
Sercan Cate+2 more
doaj +1 more source
Brimonidine tartrate effect on retinal spreading depression depends on Müller cells
Objective: Demonstrate the Brimonidine effect over Retinal Spreading Depression (SD). Brimonidine is an alpha-2–adrenergic receptor agonist, used in the management of glaucoma. Alpha2-agonists have been shown to be neuroprotective in various experimental
Vinícius Vanzan Pimentel de Oliveira+5 more
doaj +1 more source
Effects of anti-glaucoma medications on gangion cell survival: the DBA/2J mouse model [PDF]
We studied whether several agents, approved or undergoing trials in human glaucoma, were effective in preventing ganglion cell loss in the DBA/2J mouse. Adult DBA/2J mice were treated with timolol, pilocarpine, brimonidine, dorzolamide, or NMDA-receptor ...
Naskar, Rita+3 more
core +1 more source
Difference in vasoconstrictors: oxymetazoline vs. brimonidine
Topical oxymetazoline and brimonidine are the only medications approved for treating persistent facial erythema of rosacea. This review aims to investigate the efficacy, safety, pharmacodynamics, and pharmacokinetic properties of oxymetazoline and brimonidine.Phase II and phase III clinical studies evaluating oxymetazoline and brimonidine were assessed
Nwanneka Okwundu+2 more
openaire +3 more sources
Long Term Glaucoma Drug Delivery Using a Topically Retained Gel/Microsphere Eye Drop
The purpose of this study was to characterize and determine the efficacy of a long-term, non-invasive gel/microsphere (GMS) eye drop for glaucoma. This novel drug delivery system is comprised of a thermoresponsive hydrogel carrier and drug-loaded polymer
Morgan V. Fedorchak+4 more
doaj +1 more source
Brimonidine-associated uveitis – a descriptive case series
Background Anterior uveitis secondary to topical brimonidine administration is rare and not well-defined. In glaucoma patients using brimonidine, one must consider this phenomenon to avoid mis-diagnosis and over-treatment with topical steroids which in ...
Susanne Hopf+3 more
doaj +1 more source
Neurotrophic keratitis after micropulse transscleral diode laser cyclophotocoagulation. [PDF]
PurposeTo report two cases of neurotrophic keratitis (NK) after micropulse transscleral cyclophotocoagulation (MP-TCP).ObservationsTwo patients with predisposing factors for decreased corneal sensation developed NK 1 month after MP-TCP. Both patients did
Han, Ying+4 more
core +1 more source
The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review [PDF]
The acute and chronic effects of repeated intravitreal antivascular endothelial growth factor (VEGF) injections on intraocular pressure have not been fully characterized, and the development of sustained ocular hypertension could adversely affect ...
Bracha, Peter+4 more
core +1 more source